Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) will make a presentation at the BIO 12th Annual CEO and Investor Event. Their President and CEO, Jack Lief, will present an overview of the company at the event.
The conference is being held in NYC at the Waldorf-Astoria Hotel. Arena has been scheduled to deliver their presentation on February 9th at 9:30am (EST). The presentation will be webcast, both live and for replay, through the company's website.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
